Existing prognostic tools such as nomograms have many advantages in predicting cancer patients’ chances of survival and ability to enjoy a good quality of life, but also tend toward inflexibility and inability to factor in new treatments, new data, and changes in patients’ conditions. AI, however, promises to remedy these shortcomings.